Literature DB >> 22202009

miRNAs are stable in colorectal cancer archival tissue blocks.

Liselle Bovell1, Chandrakumar Shanmugam, Venkat R Katkoori, Bin Zhang, Emily Vogtmann, William E Grizzle, Upender Manne.   

Abstract

MicroRNAs (miRNAs) have prognostic and therapeutic value for colorectal cancers RCs). Although formalin-fixed paraffin-embedded (FFPE) tissues are available for biomarker studies, the stability of miRNAs in these tissues stored for long periods (more than 20 years) is unknown. The present effort involved analysis of 345 FFPE CRC tissues, stored for 6 to 28 years (1982-2004), for the expression of six miRNAs (miR-20a, miR-21, miR-106a, miR-181b, miR-203, and miR-324-5p) using TaqMan(r) microRNA assays and quantitative real-time PCR (qRT-PCR). Evaluation, by linear regression analysis, of miRNA expression among archived CRC tissues found similar levels of all six miRNAs in tissues stored over this period (correlation coefficients, R2, ranged from less than 0.0001-0.009; and t-test p-values were greater than or equal to 0.05). Thus, miRNAs are stable in FFPE tissues stored for long periods of time, and such samples can be used for discovery of biomarkers.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22202009      PMCID: PMC3681606          DOI: 10.2741/e514

Source DB:  PubMed          Journal:  Front Biosci (Elite Ed)        ISSN: 1945-0494


  7 in total

1.  Towards quantitative mRNA analysis in paraffin-embedded tissues using real-time reverse transcriptase-polymerase chain reaction: a methodological study on lymph nodes from melanoma patients.

Authors:  Helene Nortvig Abrahamsen; Torben Steiniche; Ebba Nexo; Stephen J Hamilton-Dutoit; Boe Sandahl Sorensen
Journal:  J Mol Diagn       Date:  2003-02       Impact factor: 5.568

Review 2.  How microRNAs control cell division, differentiation and death.

Authors:  Eric A Miska
Journal:  Curr Opin Genet Dev       Date:  2005-10       Impact factor: 5.578

3.  Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples.

Authors:  Yaguang Xi; Go Nakajima; Elaine Gavin; Chris G Morris; Kenji Kudo; Kazuhiko Hayashi; Jingfang Ju
Journal:  RNA       Date:  2007-08-13       Impact factor: 4.942

4.  A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia.

Authors:  George Adrian Calin; Manuela Ferracin; Amelia Cimmino; Gianpiero Di Leva; Masayoshi Shimizu; Sylwia E Wojcik; Marilena V Iorio; Rosa Visone; Nurettin Ilfer Sever; Muller Fabbri; Rodolfo Iuliano; Tiziana Palumbo; Flavia Pichiorri; Claudia Roldo; Ramiro Garzon; Cinzia Sevignani; Laura Rassenti; Hansjuerg Alder; Stefano Volinia; Chang-gong Liu; Thomas J Kipps; Massimo Negrini; Carlo M Croce
Journal:  N Engl J Med       Date:  2005-10-27       Impact factor: 91.245

5.  MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma.

Authors:  Aaron J Schetter; Suet Yi Leung; Jane J Sohn; Krista A Zanetti; Elise D Bowman; Nozomu Yanaihara; Siu Tsan Yuen; Tsun Leung Chan; Dora L W Kwong; Gordon K H Au; Chang-Gong Liu; George A Calin; Carlo M Croce; Curtis C Harris
Journal:  JAMA       Date:  2008-01-30       Impact factor: 56.272

6.  Tissues from routine pathology archives are suitable for microRNA analyses by quantitative PCR.

Authors:  U Siebolts; H Varnholt; U Drebber; H-P Dienes; C Wickenhauser; M Odenthal
Journal:  J Clin Pathol       Date:  2008-08-28       Impact factor: 3.411

7.  Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells.

Authors:  Jinghuan Li; Paul Smyth; Richard Flavin; Susanne Cahill; Karen Denning; Sinead Aherne; Simone M Guenther; John J O'Leary; Orla Sheils
Journal:  BMC Biotechnol       Date:  2007-06-29       Impact factor: 2.563

  7 in total
  18 in total

Review 1.  MicroRNAs in colorectal cancer as markers and targets: Recent advances.

Authors:  Jing-Jia Ye; Jiang Cao
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

2.  MicroRNAs as potential clinical biomarkers: emerging approaches for their detection.

Authors:  S K Srivastava; A Bhardwaj; S J Leavesley; W E Grizzle; S Singh; A P Singh
Journal:  Biotech Histochem       Date:  2013-01-07       Impact factor: 1.718

3.  Post-transcriptional processing of genetic information and its relation to cancer.

Authors:  Lr McNally; U Manne; W E Grizzle
Journal:  Biotech Histochem       Date:  2013-01-04       Impact factor: 1.718

4.  A miRNA-Based Signature Detected in Primary Melanoma Tissue Predicts Development of Brain Metastasis.

Authors:  Doug Hanniford; Judy Zhong; Lisa Koetz; Avital Gaziel-Sovran; Daniel J Lackaye; Shulian Shang; Anna Pavlick; Richard Shapiro; Russell Berman; Farbod Darvishian; Yongzhao Shao; Iman Osman; Eva Hernando
Journal:  Clin Cancer Res       Date:  2015-06-18       Impact factor: 12.531

5.  The prognostic value of microRNAs varies with patient race/ethnicity and stage of colorectal cancer.

Authors:  Liselle C Bovell; Chandrakumar Shanmugam; Balananda-Dhurjati K Putcha; Venkat R Katkoori; Bin Zhang; Sejong Bae; Karan P Singh; William E Grizzle; Upender Manne
Journal:  Clin Cancer Res       Date:  2013-05-29       Impact factor: 12.531

6.  miRNA Isolation from FFPET Specimen: A Technical Comparison of miRNA and Total RNA Isolation Methods.

Authors:  Zsófia Brigitta Nagy; Barnabás Wichmann; Alexandra Kalmár; Barbara Kinga Barták; Zsolt Tulassay; Béla Molnár
Journal:  Pathol Oncol Res       Date:  2015-12-17       Impact factor: 3.201

7.  MicroRNA Expression in Formalin-fixed Paraffin-embedded Cancer Tissue: Identifying Reference MicroRNAs and Variability.

Authors:  Mogens Karsbøl Boisen; Christian Dehlendorff; Dorte Linnemann; Nicolai Aagaard Schultz; Benny Vittrup Jensen; Estrid Vilma Solyom Høgdall; Julia Sidenius Johansen
Journal:  BMC Cancer       Date:  2015-12-29       Impact factor: 4.430

8.  Differential long-term stability of microRNAs and RNU6B snRNA in 12-20 year old archived formalin-fixed paraffin-embedded specimens.

Authors:  Sarah B Peskoe; John R Barber; Qizhi Zheng; Alan K Meeker; Angelo M De Marzo; Elizabeth A Platz; Shawn E Lupold
Journal:  BMC Cancer       Date:  2017-01-06       Impact factor: 4.430

9.  MiR-4653-3p and its target gene FRS2 are prognostic biomarkers for hormone receptor positive breast cancer patients receiving tamoxifen as adjuvant endocrine therapy.

Authors:  XiaoRong Zhong; GuiQin Xie; Zhang Zhang; Zhu Wang; Yu Wang; YanPing Wang; Yan Qiu; Li Li; Hong Bu; JiaYuan Li; Hong Zheng
Journal:  Oncotarget       Date:  2016-09-20

10.  Redefining high-risk patients with stage II colon cancer by risk index and microRNA-21: results from a population-based cohort.

Authors:  T F Hansen; S Kjær-Frifeldt; R D Christensen; S Morgenthaler; T Blondal; J Lindebjerg; F B Sørensen; A Jakobsen
Journal:  Br J Cancer       Date:  2014-07-22       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.